WALTHAM, Mass., April 4, 2011 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that results from an initial research study of galectin-3 to identify individuals at risk for the development of heart failure (HF) will be featured in a poster presentation during the American College of Cardiology 60th Annual Scientific Session (ACC.11), to be held April 2-5, 2011 in New Orleans, LA.
